Lara Young
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 486 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 486 payments — averaging $15.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- Lundbeck LLC$1K
- Otsuka America Pharmaceutical, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$867
- Alkermes, Inc.$776
- AbbVie$768
- plus $2K from 9 others
What the payments were for
- Food & beverage$7,50499%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 66 | $1,193 |
| Lundbeck LLC | 76 | $1,176 |
| Otsuka America Pharmaceutical, Inc. | 64 | $1,014 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 82 | $867 |
| Alkermes, Inc. | 43 | $776 |
| AbbVie | 51 | $768 |
| Neurocrine Biosciences, Inc. | 29 | $459 |
| Teva Pharmaceuticals USA, Inc. | 33 | $383 |
| E.r. Squibb & Sons, L.L.C. | 13 | $328 |
| Indivior Inc. | 14 | $284 |
| Vanda Pharmaceuticals Inc. | 7 | $171 |
| Noven Therapeutics, LLC | 3 | $45 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Braeburn Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,551 in reported general payments places this provider in the 90th percentile of 547 medical providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 115 | $309,425 |
| Abilify MaintenaAripiprazole | 77 | $196,878 |
| Invega TrinzaPaliperidone Palmitate | 20 | $145,304 |
| RexultiBrexpiprazole | 39 | $50,822 |
| VraylarCariprazine Hcl | 34 | $47,213 |
| LybalviOlanzapine/Samidorphan Malate | 16 | $24,703 |
| Paliperidone ErPaliperidone | 93 | $15,101 |
| FanaptIloperidone | 13 | $13,398 |
| Risperdal ConstaRisperidone Microspheres | 18 | $10,782 |
| Clozapine | 165 | $7,344 |
| Quetiapine Fumarate | 187 | $5,013 |
| Divalproex Sodium ErDivalproex Sodium | 96 | $3,287 |
| Lurasidone Hcl | 28 | $2,824 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 60 | $2,581 |
| Haloperidol Decanoate | 70 | $1,894 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Invega Trinza, Risperdal Consta | $1,193 | $465,511153 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $1,014 | $247,700116 claims |
| AbbVieVraylar | $768 | $47,21334 claims |
| Alkermes, Inc.Lybalvi | $776 | $24,70316 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $171 | $13,39813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 547 medical providers in Ohio.
Other medical in Akron
- Kodi VealeAkron$43K
- Brooke HolmgrenAkron$6K
- Shannon GhizzoniColumbus$116K
- Susan WhittCanal Winchester$74K
- Christopher FrickLima$46K
- Abbey BlairCleveland$24K
- Joana ZulaConcord Twp$23K
- Chelsea AustenColumbus$21K
- Kristen FairchildToledo$19K
- Kaitlin SchuppGahanna$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.